Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The company was looking forward to the USPTO decisions...

The company was looking forward to the USPTO decisions...

posted on Mar 18, 2009 09:43AM

From 2009-02-19:

"We remain confident that the USPTO will re-affirm the strength of the MMP™ Portfolio whenever its final actions are determined and made public."

From 2008-10-23:

"...and we look forward to the final actions by the USPTO."



Could it be, that PTSC and TPL expected a completely different outcome of the re-exam process?



Share
New Message
Please login to post a reply